A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

NCT01033123 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi